AmeriBen’s emailed spreadsheet sparks Ninth Circuit health data ruling - Human Resources Director
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.

One emailed spreadsheet unlocked a federal class action and a Ninth Circuit ruling that changes how health data breaches play out in court.
In August 2023, IEC Group - a benefits administrator operating as AmeriBen - sent letters to two health plan members with an uncomfortable admission. An associate had emailed a spreadsheet containing their confidential health information to “one or more plan members.” The data that may have been exposed included names, provider names, claim numbers, dates of service, and amounts billed or paid.
This article is an excerpt. To read the full content, visit the original source. Human Resources Director
Related articles
Ninth inning homer ends Goldeyes' season - DiscoverWestman
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
0 comments
No comments yet. Be the first to share your thoughts!